GLP-1 receptor agonist 14
3-[1-[2-[(4S)-2-(3-cyclopropyl-4-fluorophenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]-7-[(4R)-2,2-dimethyloxan-4-yl]indolizin-3-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one
Molecular Identity
GLP-1 receptor agonist 14
3-[1-[2-[(4S)-2-(3-cyclopropyl-4-fluorophenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]-7-[(4R)-2,2-dimethyloxan-4-yl]indolizin-3-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one
PubChem CID: 167350327
2D Structure
Properties
C48H46F2N10O5
Molecular Formula
880.90
Molecular Weight
g/mol
880.3621
Exact Mass
Da
6.5
XLogP
Above Lipinski threshold
144
TPSA
May have limited oral absorption
1
H-Bond Donors
10
H-Bond Acceptors
1970
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(13)
GLP-1 receptor agonist 143011682-51-92758659-09-3ECC5004AZD5004orb2695198SCHEMBL25023844SCHEMBL30176153EX-A8451AT45175BP-50436HY-156968CS-0905206
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to GLP-1 receptor agonist 14
Loading drug network...